Connect Biopharma Holdings Limited
CNTB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $78 | $106 | $80 | $268 |
| Short-Term Investments | $15 | $13 | $75 | $0 |
| Receivables | $1 | $0 | $0 | $7 |
| Inventory | $0 | $0 | -$6 | -$0 |
| Other Curr. Assets | $2 | $2 | $0 | $0 |
| Total Curr. Assets | $97 | $123 | $158 | $275 |
| Property Plant & Equip (Net) | $4 | $5 | $5 | $13 |
| Goodwill | $0 | $0 | $0 | -$3 |
| Intangibles | $0 | $0 | $3 | $4 |
| Long-Term Investments | $0 | $0 | $10 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $3 |
| Total NC Assets | $4 | $5 | $19 | $16 |
| Other Assets | $0 | $0 | -$0 | $0 |
| Total Assets | $101 | $126 | $177 | $291 |
| Liabilities | – | – | – | – |
| Payables | $0 | $8 | $12 | $13 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $13 | $0 | $0 |
| Other Curr. Liab. | $8 | $4 | $4 | $5 |
| Total Curr. Liab. | $8 | $25 | $16 | $18 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $1 | $1 |
| Deferred Tax Liab, NC | $0 | $0 | -$1 | -$1 |
| Other NC Liab. | $1 | $0 | $0 | $1 |
| Total NC Liab. | $1 | $1 | $1 | $1 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $9 | $25 | $17 | $19 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$345 | -$330 | -$464 | -$373 |
| AOCI | -$2 | $12 | $10 | -$6 |
| Other Equity | $439 | $629 | $7 | $629 |
| Total Equity | $92 | $101 | -$464 | $273 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $101 | $126 | -$447 | $291 |
| Net Debt | -$78 | -$105 | -$80 | -$268 |